Functionally, EIF3J-AS1 overexpression significantly enhanced the proliferation of U251 and U87 cells, whereas its knockdown significantly suppressed glioma cell proliferation (Fig. 1I, J). This evidence concerns the gene EIF3J and central nervous system cancer.